ATERA specializes in the advancement, validation, commercialization and manufacturing of advanced tissue models as cost-effective, high-quality, reliable and more conscientious alternatives for animal trials. Under the deal, ATERA will advance 3D human skin models of Epidermolysis Bullosa to assess the efficiency of INM-750 and probe the beneficial effects of topically put INM-750 at ultra-structural molecular and cellular levels.
As the marijuana industry begins to struggle with supply and demand conditions in states where cannabis is legal at some level, the number of cannabis grow facilities and along with the introduction of new CBD products continue to rise at an astounding rate.
According to a research report by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is projected to grow at a CAGR of 21.1% from 2017 to 2024. By 2024, the projected demand of cannabis will continue to rise for both recreational and medical use, while reaching an estimated global sales value of $63.5 billion .
A U.S. House panel briefly debated — but did not vote on — an amendment to give marijuana businesses greater access to banks late on Thursday night. Under current federal prohibition laws, many financial services providers are reluctant to work with cannabis businesses for fear of being prosecuted for money laundering. As a result, many state-legal marijuana growers and sellers operate on a cash-only basis, which makes them targets for robberies.
SANTA ANA, Calif. Kush Bottles, Inc. (OTCQB: KSHB), a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry, today reported financial results for its third fiscal quarter ended May 31, 2017 .
A better than expected quarter has Clarus analyst Noel Atkinson raising his price target on Aphria (TSXV:APH).
On Wednesday, Aphria reported its Q4 and fiscal 2017 results. In the fourth quarter, the company lost $2.6-million on revenue of $5.7-million, a topline that was up 106 per cent over the same period last year.
ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) this morning announced that its common shares have been approved for trading on the OTCQB Venture Market, under the symbol ‘ABCCF’, and on the Frankfurt Stock Exchange, under the symbol ‘23Q’.
CURE Pharmaceutical (OTCQB:CURR), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences (Nasdaq: TRPX ), a specialty clinical-stage pharmaceutical company dedicated to the development of cannabinoid-based drugs headquartered in Israel, announced today that they signed a memorandum of understanding (MOU) to enter into a research collaboration with Assuta Medical Centers Ltd.
Strainprint, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg , Dr. Sana-Ara Ahmed , and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company specializing in the development of advanced human tissue models.
ABcann Global Corporation (TSXV: ABCN) yesterday announced its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ). The ETF is a first-of-its-kind index offering investors direct exposure to a basket of North American life sciences companies with significant business activities in the medical marijuana sector.
ABcann Global Corporation (TSX-V: ABCN ) is pleased to announce its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ ).
Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) announces the proposed offering of up to 80 million share purchase warrants. Each warrant will be offered for a consideration of 10 cents (CDN) per warrant for a total of gross proceeds of up to $8 million dollars and are exercisable into one common share for the price of $2.90 per share for a period of 3 years from the date of closing (the "warrants").
Tokyo Smoke to open Canadian flagship retail store on Queen Street West July 20. 1,000 square foot space, designed by DesignAgency, to offer coffee, carefully selected cannabis accessories, apparel and exclusive Queen West merchandise and perk-filled, unlimited coffee membership
New research shows that cannabis can not only treat migraines and cluster headaches, but do so more effectively compared to conventional treatment. Participants in the study suffered from either chronic migraines or cluster headaches. Migraines cause all-over headache pain and nausea as well as a sensitivity to light and sound. Cluster headaches typically cause pain in one area, usually within proximity to the eyes. Researchers needed to determine the actual dosage they would use in the study.
